Can inflammatory cytokine signaling disrupt sex-hormone biology?

Chronic inflammation serves as a major driver of endocrine dysfunction by simultaneously halting sex steroid production and disabling downstream receptor responses.

Mechanistic pathways of disruption

• Steroidogenic enzyme suppression: Inflammatory cytokines—specifically TNF-α, IL-1β, and IL-6—directly downregulate key biosynthetic enzymes, including CYP19A1 (aromatase) and CYP17A1 in ovarian and testicular cells. This creates localized resistance to FSH, LH, and hCG, resulting in significantly diminished circulating levels of estradiol and testosterone.
• Receptor interference and co-activator sequestration: Cytokines disrupt estrogen (ER) and androgen (AR) receptor signaling through direct physical cross-talk. Activated NF-κB p65 subunits physically interact with ER and AR to block their transcriptional activity. Additionally, active cytokine signaling sequesters the shared co-activator CBP/p300, preventing hormone-receptor-regulated gene expression.
• Receptor isoform shifting: Cytokines actively remodel tissue receptor landscapes; for instance, IL-6 and IL-17 activate JAK/STAT3 and MAPK pathways to downregulate the antiproliferative ERβ isoform while upregulating ERα, altering tissue-specific hormone sensitivity and homeostasis.

Bidirectional feedback and clinical implications

• The pathogenic feed-forward loop: Under homeostatic conditions, ligand-bound ER and AR trans-repress NF-κB and JAK/STAT3 to suppress cytokine transcription. When inflammatory cytokines suppress hormone production and receptor signaling, this natural anti-inflammatory restraint is lost. The resulting depletion of sex steroids allows systemic TNF-α and IL-6 to rise further, perpetuating a chronic cycle of inflammation and endocrine decline.

Bottom line

• Inflammatory cytokines disrupt sex-hormone biology through a double-hit mechanism: directly suppressing rate-limiting enzymes (CYP19A1/CYP17A1) to lower hormone levels, and impairing receptor transcription via NF-κB cross-talk and CBP/p300 sequestration, establishing a self-perpetuating cycle of inflammation and endocrine decline.